57 related articles for article (PubMed ID: 30251682)
1. Molecular and cellular basis of ornithine δ-aminotransferase deficiency caused by the V332M mutation associated with gyrate atrophy of the choroid and retina.
Montioli R; Desbats MA; Grottelli S; Doimo M; Bellezza I; Borri Voltattorni C; Salviati L; Cellini B
Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3629-3638. PubMed ID: 30251682
[TBL] [Abstract][Full Text] [Related]
2. Genetic correction and analysis of induced pluripotent stem cells from a patient with gyrate atrophy.
Howden SE; Gore A; Li Z; Fung HL; Nisler BS; Nie J; Chen G; McIntosh BE; Gulbranson DR; Diol NR; Taapken SM; Vereide DT; Montgomery KD; Zhang K; Gamm DM; Thomson JA
Proc Natl Acad Sci U S A; 2011 Apr; 108(16):6537-42. PubMed ID: 21464322
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics of gyrate atrophy compared with a gyrate atrophy-like retinal phenotype.
Pauleikhoff L; Weisschuh N; Lentzsch A; Spital G; Krohne TU; Agostini H; Lange CAK
Eur J Ophthalmol; 2024 Jan; 34(1):79-88. PubMed ID: 37218157
[TBL] [Abstract][Full Text] [Related]
4. Clinical, biochemical and molecular analysis in a cohort of individuals with gyrate atrophy.
Palmer E; Stepien KM; Campbell C; Barton S; Iosifidis C; Ghosh A; Broomfield A; Woodall A; Wilcox G; Sergouniotis PI; Black GC
Orphanet J Rare Dis; 2023 Sep; 18(1):265. PubMed ID: 37667371
[TBL] [Abstract][Full Text] [Related]
5. Selective Targeting by a Mechanism-Based Inactivator against Pyridoxal 5'-Phosphate-Dependent Enzymes: Mechanisms of Inactivation and Alternative Turnover.
Mascarenhas R; Le HV; Clevenger KD; Lehrer HJ; Ringe D; Kelleher NL; Silverman RB; Liu D
Biochemistry; 2017 Sep; 56(37):4951-4961. PubMed ID: 28816437
[TBL] [Abstract][Full Text] [Related]
6. Biochemical characterization of pea ornithine-delta-aminotransferase: substrate specificity and inhibition by di- and polyamines.
Stránská J; Tylichová M; Kopecný D; Snégaroff J; Sebela M
Biochimie; 2010 Aug; 92(8):940-8. PubMed ID: 20381578
[TBL] [Abstract][Full Text] [Related]
7. Gyrate atrophy of the choroid and retina: Update on diagnosis and treatment.
Merino Diez MT; Soria Prada C; Zamorano Aleixandre M; Gonzalez-Lopez JJ
Arch Soc Esp Oftalmol (Engl Ed); 2024 Apr; ():. PubMed ID: 38663712
[TBL] [Abstract][Full Text] [Related]
8. Ornithine delta-aminotransferase: An enzyme implicated in salt tolerance in higher plants.
Stránská J; Kopecný D; Tylichová M; Snégaroff J; Sebela M
Plant Signal Behav; 2008 Nov; 3(11):929-35. PubMed ID: 19513195
[TBL] [Abstract][Full Text] [Related]
9. Vision on gyrate atrophy: why treat the eye?
Bergen AA; Buijs MJ; Ten Asbroek AL; Balfoort BM; Boon CJ; ; Brands MM; Wanders RJ; van Karnebeek CD; Houtkooper RH
EMBO Mol Med; 2024 Jan; 16(1):4-7. PubMed ID: 38177529
[TBL] [Abstract][Full Text] [Related]
10. Determination of the pH dependence, substrate specificity, and turnovers of alternative substrates for human ornithine aminotransferase.
Butrin A; Butrin A; Wawrzak Z; Moran GR; Liu D
J Biol Chem; 2022 Jun; 298(6):101969. PubMed ID: 35460691
[TBL] [Abstract][Full Text] [Related]
11. Structural and Mechanistic Basis for the Inactivation of Human Ornithine Aminotransferase by (3
Shen S; Butrin A; Beaupre BA; Ferreira GM; Doubleday PF; Grass DH; Zhu W; Kelleher NL; Moran GR; Liu D; Silverman RB
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770800
[TBL] [Abstract][Full Text] [Related]
12. The Proline/Citrulline Ratio as a Biomarker for OAT Deficiency in Early Infancy.
de Sain-van der Velden MG; Rinaldo P; Elvers B; Henderson M; Walter JH; Prinsen BH; Verhoeven-Duif NM; de Koning TJ; van Hasselt P
JIMD Rep; 2012; 6():95-9. PubMed ID: 23430945
[TBL] [Abstract][Full Text] [Related]
13. Atypical Presentation and Delayed Diagnosis of Gyrate Atrophy: Case Reports of Two Siblings.
Ceran TH; Gediz BS; Sonmez K
Beyoglu Eye J; 2023; 8(4):301-307. PubMed ID: 38089080
[TBL] [Abstract][Full Text] [Related]
14. Deficit of human ornithine aminotransferase in gyrate atrophy: Molecular, cellular, and clinical aspects.
Montioli R; Bellezza I; Desbats MA; Borri Voltattorni C; Salviati L; Cellini B
Biochim Biophys Acta Proteins Proteom; 2021 Jan; 1869(1):140555. PubMed ID: 33068755
[TBL] [Abstract][Full Text] [Related]
15. New pathogenic variants in COQ4 cause ataxia and neurodevelopmental disorder without detectable CoQ
Mero S; Salviati L; Leuzzi V; Rubegni A; Calderan C; Nardecchia F; Galatolo D; Desbats MA; Naef V; Gemignani F; Novelli M; Tessa A; Battini R; Santorelli FM; Marchese M
J Neurol; 2021 Sep; 268(9):3381-3389. PubMed ID: 33704555
[TBL] [Abstract][Full Text] [Related]
16. The multiple roles of coenzyme Q in cellular homeostasis and their relevance for the pathogenesis of coenzyme Q deficiency.
Baschiera E; Sorrentino U; Calderan C; Desbats MA; Salviati L
Free Radic Biol Med; 2021 Apr; 166():277-286. PubMed ID: 33667628
[TBL] [Abstract][Full Text] [Related]
17. Biallelic mutations in the
Morbidoni V; Agolini E; Slep KC; Pannone L; Zuccarello D; Cassina M; Grosso E; Gai G; Salviati L; Dallapiccola B; Novelli A; Martinelli S; Trevisson E
J Med Genet; 2021 Aug; 58(8):526-533. PubMed ID: 32747439
[TBL] [Abstract][Full Text] [Related]
18. A Novel Ornithine Aminotransferase Splice Site Mutation Causes Vitamin B6-Responsive Gyrate Atrophy.
Molaei Ramshe S; Zardadi S; Alehabib E; Nourinia R; Jamshidi J; Soosanabadi M; Darvish H
J Ophthalmic Vis Res; 2024; 19(1):118-132. PubMed ID: 38638626
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
